The progression of NAFLD alters the secretion of hepatokines such as fetuin-A, fetuin-B, and dipeptidyl peptidase-426,27, and we evaluated an association between fetuin-A and DPN. This evidence concerns the gene AHSG and metabolic dysfunction-associated steatotic liver disease.